These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27910712)

  • 1. Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic-pharmacodynamic modeling approach for quantitative prediction of skin absorption.
    Elkomy MH; El Menshawe SF; Eid HM; Ali AM
    Drug Dev Ind Pharm; 2017 Apr; 43(4):531-544. PubMed ID: 27910712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
    Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
    Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
    Khurana S; Bedi PM; Jain NK
    Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats.
    Bawazeer S; El-Telbany DFA; Al-Sawahli MM; Zayed G; Keed AAA; Abdelaziz AE; Abdel-Naby DH
    Drug Deliv; 2020 Dec; 27(1):1218-1230. PubMed ID: 32772730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
    Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
    Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
    Al-Mahallawi AM; Abdelbary AA; Aburahma MH
    Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
    Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
    Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery.
    Gönüllü Ü; Üner M; Yener G; Karaman EF; Aydoğmuş Z
    Acta Pharm; 2015 Mar; 65(1):1-13. PubMed ID: 25781700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology.
    Sinha P; Srivastava S; Mishra N; Singh DK; Luqman S; Chanda D; Yadav NP
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1434-45. PubMed ID: 26821208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
    Kalita B; Das MK; Sarma M; Deka A
    AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
    Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
    Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies.
    Bhaskar K; Anbu J; Ravichandiran V; Venkateswarlu V; Rao YM
    Lipids Health Dis; 2009 Feb; 8():6. PubMed ID: 19243632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment.
    Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S
    AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats.
    Fouad SA; Badr TA; Abdelbary A; Fadel M; Abdelmonem R; Jasti BR; El-Nabarawi M
    AAPS PharmSciTech; 2024 Oct; 25(7):237. PubMed ID: 39384727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
    Kim T; Kang E; Chun I; Gwak H
    J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.
    Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q
    Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.